Skip Navigation
  Print Page

Spina Bifida: NICHD Research Goals

Skip sharing on social media links
Share this:

Myelomeningocele is the most common severely disabling birth defect in North America. The NICHD integrates extensive intramural and extramural programs to advance treatment for spina bifida, provides effective support and rehabilitation, and investigates possible avenues for prevention. The NICHD’s research portfolio includes:

  • Genetic determinants of spina bifida
  • Prenatal diagnosis and repair
  • Defining developmental effects of spina bifida
  • Assessing interventions to support robust motor development, learning capacity, and social integration
Last Updated Date: 11/30/2012
Last Reviewed Date: 11/30/2012
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology